Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 11 - Jul 16
For Your Every Summer RSVP, with Code: SUMMER15
Description
CagriSema vs Retatrutide 2026: Approval & Data Semaglutide vs. Ozempic Island Rheumatology and Osteoporosis, PC Zepbound vs. Retatrutide: How These Weight Loss Drugs Compare Found Comprehensive Semaglutide Data & Statistics: Weight Loss & Diabetes
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.0 ★★★★★
Based on 230 reviews
Sort
Product Reviews
★★★★★ 5
Amazing brand
Color: Silver Gold
Love these watches so much.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 13, 2026
★★★★★ 5
good for big wrists
my wrist is almost 9 inches so some choices are too small. plus I like a slightly loose fit rather than snug. it's beautiful just like the pictures. happy with it.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 10, 2022
★★★★★ 5
Husband loved the watch
Husband loved it! Very nice and heavy
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 29, 2026
★★★★★ 5
Es igual como se muestra en la imagen
Excelente
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 15, 2025
★★★★★ 5
Great watch on that price
Amazing
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 1, 2025
recommand products
Novo Nordisk testing its blockbuster GLP-1 drugs in Alzheimer's
28.97
GLP-1s for Alzheimer's: Novo Nordisk announces trial conclusion
28.28
Novo's Wegovy becomes first GLP-1 drug approved for MASH
24.88
Use of GLP-1 RAs Associated With Increased Risk of NAION in Patients With Diabetes
25.80
Ophthalmic Complications Observed After Use of GLP-1 Agonists
23.21